Development and Validation of a Diethyl Phosphite Content in Foscarnet Sodium USP by GC MS Technique
Journal of Pharmaceutical Research International,
A simple, rapid, selective, and reproducible Gas chromatographic mass spectrometry (GC-MS) method has been developed and validated for the estimation of Diethyl Phosphite content in Foscarnet Sodium USP Drug substance. The drugs were estimated using HP-5, Length-30 M, Internal diameter 0.32 mm; Film thickness 1 μ at a total flow rate of 11.9 ml/min, and column flow of 1.49 ml/min was used for the separation. Flow control mode was pressure. Column oven temperature 70°C and injector temperature 220°C. Oven program modified for proper elution of peak. The linearity range used was 0.025-0.120µg/ml and (Rt) was 6.7 min. The correlation coefficient values were found to be 0.997. Precession studies showed % RSD values less than 15.0% for all the selected concentrations. The percentage recovery of Diethyl phosphite from LOQ to 150% was found in range of 100.7 -116.7%. The content results of Phophite content were within the limits of less than 0.12 ppm. The method was validated as per the International Conference on Harmonization (ICH) guidelines. The developed method was successfully used for the quantitative analysis of commercially available dosage forms.
- foscarnet sodium
- diethyl phosphate
- genotoxic impurity
How to Cite
Oberg B. Antiviral drugs: Pharmacol Ther. 1989;40(2):213-85. DOI: 10.1016/0163-7258(89)90097-1 PMID: 2543994 Rx list, Foscarnet sodium description.
Wagstaff AJ, Bryson HM. Foscarnet. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with viral infections drugs. 1994;48(2):199-226. DOI: 10.2165/00003495-199448020-00007
ICH guidelines; Q8(R2), Harmonised tripartite guideline, on pharmaceutical development, proceedings of the international conference on harmonization; 2009.
ICH guidelines; Q3A (R2), Impurities in new drug substances, in: International Conference on Harmonization, Geneva; 2006.
ICH guidelines, Q1A(R2); Stability Testing of New Drug Substances and Products, International Council for Harmonization Geneva; 2003 Available:http://wwwichorg/products/guidelines/quality/article/quality-guidelines/html
ICH guidelines, Q2 (R1): Validation of Analytical Procedures: Text and Methodology, International Conference on Harmonization Geneva; 2005. Available:http://wwwichorg/products/guidelines/quality/article/quality-guidelines/html
ICH guideline M7(R1) on assessment and control of DNA reactive(mutagenic) impurities in pharmaceuticals to limit potential carcinogenic risk.
Jeffery GH. Bassett J. Mandham J. and. Denny RC. Editors. Vogel’s text book of quantitative chemical analysis, Longman Scientific and Technical Pub U.K. 1994;5:3-4.
Kar A. “Pharmaceutical Drug Analysis”, 2nd ed. New age international limited publishers. 2005;452-474.
Panchumarthy R, Naga N. Pravallika D, Navya S. “A review on step-by-step analytical method validation, IOSR Journal of Pharmacy”. 2015:5(10):07-19.
Skoog D, Holler J, Crouch S. “Principles of Instrumental Analysis”, 6th ed. Belmont, CA: Thomson Brooks/Cole. 2007;169–173.
Sharma BK. Instrumental methods of chemical analysis. 25th ed. Goel Publication Co.; Meerut. 2002;3-6.
Chatwal GR, Anand SK. “Instrumental methods of chemical analysis. 5th ed. Himalaya Publishing House”; Delhi. 2007;2.150, 2.566-2.585, 2.624-2.630.
Abstract View: 0 times
PDF Download: 0 times